mal intelligence, and 1/3 will have central nervous system dysfunction (in the past, half of these would die at birth or in the first year, or have such severe involvement as to be lethal) [Hall, 2012] . Amyoplasia is the most common form of arthrogryposis occurring in about 1/10,000 live births . Amyoplasia is recognized by its unique clinical features. Individuals with this form usually do surprisingly well and have normal to high intelligence, but it appears to be totally sporadic (although increased in one of monozygotic twins). Most other recognizable types of arthrogryposis have a genetic basis (i.e., single gene mutation) [Michalk et al., 2008; Hall, 2014; Hunter et al., 2015; Bayram et al., 2016] .
Over the last 40 years, the heterogeneity and diversity of specific disorders has begun to be recognized and delineated. Over 400 different specific conditions with arthrogryposis have been recognized and over 320 genes implicated [Michalk et al., 2008; Hall, 2014; Hunter et al., 2015; Bayram et al., 2016] . There is a need to annotate and functionally group these genes into known pathways and biological processes. Such a grouping has potential for identification and prioritization of other candidate disease genes. Additionally, it should inform the development of better molecular diagnostic techniques and specific therapeutic options. Until now, nonspecific physical therapy to loosen contractures and realign joints, casting, and surgeries to improve joint function have been the standard therapy.
It is clear that anything which limits or interferes with fetal movement may lead to congenital contractures (limitation of joint movement) [Hall, 2012 [Hall, , 2014 . These include myopathic processes with structural elements, ion channels, and mechanosensing elements; neuropathic processes including central and peripheral nerves, anterior horn cells, and brain organization and function; myelin deficiency; neuromotor endplate abnormalities; connective tissue disorders; limitation of space and constraint in utero; vascular compromise (decreased blood flow to the placenta or to the embryo/fetus); teratogenic exposure, and maternal illnesses. Any of the above-mentioned processes or clinical situations may lead to decreased fetal movement. Even hypotonia of the fetus may be severe enough to decrease in utero movement sufficiently, leading to contractures at birth.
We performed an enrichment analysis (EA) to identify overrepresented functional biological groupings within the list of assembled 320 genes ( table 1 ) . EA is a common bioinformatic technique to describe common biological aspects associated with a list of genes. Gene lists are often the output of high-throughput genomics experiment or, in the case here, a listing of genes associated with a disease process. EA involves computing an enrichment statistic across a corpus of gene sets to identify overand/or underrepresented gene sets in the gene list being interrogated. A corpus of gene sets is a collection of genes categorized together based on some biological aspect or property. The outcome of EA results in a list of statistically enriched gene sets describing the biological properties common within the given gene list. This allows for biologist interpretation of gene lists, whether it is a differential gene expression list or a list of genes associated with a disease state, such as the syndrome of arthrogryposis detailed in this review.
Popular gene set libraries used for EA include manually curated gene sets representing canonical signaling pathways, such as Reactome [Croft et al., 2014] , and structured gene sets based on the Gene Ontology (GO) resource [Gene Ontology Consortium, 2015] . The GO is a resource, in the form of a structured ontology, which describes and categorizes gene product functions in distinct categories and the relationships between them. The GO functional categories are classified in 3 general categories: biological process, molecular function, and cellular component. The biological process category contains individual GO terms that describe processes associated with molecular events and pathways representing multiprotein-dependent functions. The molecular function category, in contrast, describes basic gene functions at the molecular level. Lastly, the cellular component category describes the location, environment, or part of the cell, so that the gene product can be located.
The EA for this review was performed using the software tool ClueGO [Bindea et al., 2009] . ClueGO calculates enrichment scores for selected gene sets against a user-provided gene list. Our analysis was performed using the biological process and cellular component categories of the gene ontology. The biological process category was selected because it captures functional descriptions that provide a better biological interpretation based on multicomponent signaling and functional groupings. The cellular component category was selected as it provides details on not only intracellular locations, but also higher ordered structures such as the 'synaptic membrane'. The other main benefit of performing EA with ClueGO is that it groups similar GO terms and provides a network-based view of the enriched GO terms. This is important in that it aides interpretation of results by grouping related GO terms, based on shared gene members, presenting the results as a network. Since GO has a hierarchical ontological-based structure, GO HER3, LCCS2, Schwann cell differentiation, peripheral nervous system development karger.com/doi/10.1159/000446617 for all online suppl. material). The automatic grouping of terms, performed by ClueGO, assigned them to 22 groups based on overlapping gene membership measured by the kappa score statistic (online suppl. table 2). The number of GO terms in the groups varied from a maximum of 57 to 8 groups with just 1 term each and 9 groups with shared GO terms. The network representation is displayed in figure 1 . The network is composed of nodes representing enriched GO terms connected by kappa scores that are a measure of gene overlap between terms. The node color represents the membership in one of the ClueGO determined clusters. While ClueGo attempts to determine the most representative GO term to name the grouped terms, we have provided our own annotation grouping for greater clarity in interpretation and meaning (online suppl. table 3). This grouping is indicated by the shading overlaid on the network with an annotated group labeled with a summary title of the underlying GO terms in the group.
The purpose of this paper is to highlight the genes in which mutations have been identified to be associated with arthrogryposis in order to emphasize the importance of defining the other genes in their developmental pathways. This is in order to (1) develop a logical diagnostic approach and (2) to begin to think about specific therapies for specific disorders. For instance, in the disorders of neuromuscular endplate related to fetal endplate receptor, they seem to respond to increased neurotransmitters (a readily available drug used to myasthenia gravis), which then seem to allow the normal adult endplate to be able to function [Michalk et al., 2008] .
Perhaps the most puzzling aspect of arthrogryposis is why extra connective tissue/fibrosis is deposited around the immobile joint(s) in the fetus. Is the process related to immobilizing that occurs with a sprain or fracture, where pain leads to an individual immobilizing the surrounding joints which then develop contractures? This process would be magnified as the fetus grows. Or is there another unique developmental process of fibrosis in young individuals? Is the process similar to tendon and ligament formation? Are connective tissue stem cells overstimulated or more susceptible in the fetus? Is this excess of connective tissue an unusual scar of some type? Is one of Fig. 1 . GO enrichment network. The nodes in the network represent a specific GO term. The edges connecting the nodes are based on the kappa statistic that measures the overlap of shared genes between terms. The node colors correspond to the ClueGOdetermined GO term clusters. The shadings represent author-annotated groupings with a summary title. the connective tissue growth factors a potential therapy for arthrogryposis contractures of the future?
In this molecular era, syndromes of congenital anomalies give insight into normal developmental processes and their secondary and tertiary effects. In the case of arthrogryposis, so many of the features are secondary deformations related to fetal non-movement [Hall, 2009] . Nevertheless, all of the features which are part of the natural history of the specific disorder are important for families to know about in order to plan effectively.
The specific gene mutation in a specific disorder is acting against the rest of the individual's genome, epigenetics, and environmental history. In the course of development, the embryo fetus goes through many physiological developmental stages. The vulnerabilities, timing of insults, involved polymorphisms along a pathway, and gene action also provide insights into the human normal and abnormal developmental processes.
The work up of affected individuals [Hall, 2012 [Hall, , 2014 ] as well as the known genes are covered elsewhere; the associated syndromes are found in OMIM (http://www. omim.org/) [Hall, 2012 [Hall, , 2014 Hunter et al., 2015; Bayram et al., 2016] . Table 1 outlines gene ontology categories and begins to suggest prime candidates for recognizing critical pathways involved in normal fetal movement. Interestingly, many candidate genes show up in several ontology categories. This may relate to different domains of the genes, to alternative splicing, or to the 'recycling' of pathways for different functions.
It is hoped that this exercise is useful to those reflecting on the many mechanisms and structures involved in the development of movement, and fetal movement in particular. The listing of all genes recognized to be involved in arthrogryposis at this time is obviously an incomplete list. Some genes are involved in several disorders which were clinically thought to be distinct (perhaps related to the specific nucleotide replacement or perhaps related to various modifiers). Once a group of families with a specific mutation has their whole genome analyzed, the variation in clinical phenotype can be elucidated and important modifiers identified.
Many specific single gene disorders have intra-and interfamilial variability as to how severe the contractures are at birth, what positioning they take, or whether contractures are even present. For instance, several forms of dominant distal arthrogryposis have completely unaffected carrier individuals [Kimber et al., 2012] .
It is also hoped that this listing will point to other genes involved in ontological processes that may also result in arthrogryposis and be part of the pathways leading to normal fetal movement -thereby providing better diagnostic precision among the present quagmire of interpretation of the whole genome and even exome sequencing. Ultimately, specific therapies may involve alternative pathways and enhance the affected pathway.
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